INTRODUCTION
Prostate cancer is one of the most common malignancies in men with more than 1 million new cases being diagnosed worldwide every year [1] . Despite a 5-year relative survival rate of 99.7% for all pathological stages, prostate cancer remains the second leading cause of cancer deaths in men [2, 3] . Germany and does not necessarily reflect a ''paradigm shift'' towards active surveillance as stated in the literature earlier [5] .
Today, a patient's individual decision between surgery or alternative approaches is not just based on relatively objective clinical parameters; instead, individual factors such as family considerations, social environment, social status, and factors like comorbidities, patient-consultant relationship, and logistic factors, such as accessibility to hospitals and to the latest surgical techniques, are gaining more and more importance [6] .
While the number of RP procedures has decreased over the last decade, the technological progress made in the performance of RP procedures has increased especially since the introduction of the robot-assisted radical prostatectomy (RARP) in 2000 [4, 7] . In the USA, RARP already represents the most frequently used surgical approach for treatment of localized prostate cancer. Current data suggests that in 2008, 80% of RPs in the USA were already robot-assisted and the numbers are increasing [8, 9] . In comparison, the proportion of robot-assisted prostatectomies in Germany was 25.2% in 2013 [4] .
Data from the literature and from the Federal Statistical Office in Germany suggest a trend towards an increase of minimally invasive RP procedures performed in Germany over recent years; however, no distinction was made between conventional and robot-assisted laparoscopy [10] . The datasets analyzed during the current study are available from the corresponding author on reasonable request.
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DISCUSSION
Over recent years there has been a significant change in the management of localized prostate cancer. As a result of recommendations against PSA testing and screening there has been a decline in RPs as well as pelvic lymph node dissection (PLND) and high dose rate (HDR) brachytherapy over recent years [11, 12] .
Furthermore, more and more patients with low-risk tumors are included in active surveillance programs; patients with locally advanced disease or lymph node metastases are treated in multimodal concepts with surgery and consecutive radiation therapy. At the same time, the implementation of robot-assisted surgery has led to a broader availability of minimally invasive procedures for the treatment of prostate cancer. These trends were also apparent in our database.
The current analysis has shown significant changes in the surgical management of prostate cancer: our data showed fewer surgeries of patients with low-risk tumors, while more patients with intermediate-and high-risk cancer were operated on.
Our study showed an increase in the mean age of men undergoing RP from 65.0 to 65.7 years. This seems to be consistent with other findings in the literature that suggest an overall trend to operate on older patients today than was the case 10-15 years ago: single-center data from a European tertiary-care institution (Martini-Klinik) showed a mean patient age increase of 3 years in men who underwent RP over a time frame of 9 years between 2000 and 2009 [13] . Furthermore, an analysis from the Federal Statistical Office in Germany that evaluated all RPs performed in Germany in the [14] . Furthermore, the more frequent performance of nerve-sparing procedures might have contributed to a longer surgical time.
Our data showed an increase in nerve-sparing procedures by 4.5% over study period of 9 years (58.7% vs. 63.2%, p\0.0001).
This confirms the desire to achieve better functional outcomes after surgery which can be explained by the demographic changes in highly developed countries and better education of patients concerning the preservation of continence and erectile function. Unfortunately, we were not able to extract postoperative functional data from the database. Therefore we cannot conclude that the higher rate of nerve sparing resulted in a lower rate of erectile dysfunction following RP [7, 15] .
In patients included in our analysis the median hospitalization time as well as the catheter-indwelling time both significantly decreased by 1 day during the study period of 9 years (9 vs. 8 days, 9.9 vs. 8.9 days, p\0.0001). Beside the general aspects of changing healthcare systems and the related economic reasons in hospitals to keep hospital stays for patients as short as possible, these findings can also be explained by the fact that according to data in the literature RARPs not only promise better functional but also better perioperative outcomes, e.g., a shorter hospitalization and catheter indwelling time with RARP compared to open RP [7, 14, 16] . A similar analysis of data from the same database showed that hospitalization time decreased by 2 days between 2005 and 2008 (10 vs. 8 days) [10] . One argument of the advocates of RARP is the reduced length of hospitalization and therefore improved quality of life for the patient [8] [21] . Our analysis did not include data about the number of positive biopsies, the ratio of cancer within this biopsy, or any information about the clinical T stage of these patients, which is essential for clinical decision-making. Additionally, before drawing conclusions from the data analyzed in this study one has to take into account the weaknesses of data arising from a multicenter Internet-based database like this. As there are typically no study nurses or dedicated clinical staff in the different centers responsible for ensuring a timely and correct documentation of complete data in all patients, the integrity of the different parameters is not always given.
Thus, one major limitation of the current study is the high percentage of patients with missing data and/or lost to follow-up, which could have resulted in a selection bias. Nevertheless, this database is one of the biggest sources of data on RP in Germany and therefore it most likely represents the clinical reality in Germany.
CONCLUSION
Our data confirms the trend towards modern laparoscopic surgical techniques. In particular, robot-assisted radical prostatectomy is gaining more and more importance across a broad range of prostate cancer centers in Germany. 
